In addition, overexpression of SPON2 enhanced, while knockdown of SPON2 reduced IL10, CCL2 and CSF1 expression levels (Fig. 4e-f) and secretion (Fig. 4h-j) in CRC tumor cells. The gene discussed is CCL2; the disease is colorectal carcinoma.